Magrolimab Achieves Positive Results in Ongoing Phase 1b Trial
News
Gilead Sciences’ investigational therapy magrolimab was well-tolerated and effective in untreated acute myeloid leukemia (AML) patients ineligible for intensive chemotherapy, according ... Read more